BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11473569)

  • 1. Cardiovascular effects of beta 3-adrenoceptor stimulation in perinephritic hypertension.
    Donckier JE; Massart PE; Van Mechelen H; Heyndrickx GR; Gauthier C; Balligand JL
    Eur J Clin Invest; 2001 Aug; 31(8):681-9. PubMed ID: 11473569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
    Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
    J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor.
    Tavernier G; Toumaniantz G; Erfanian M; Heymann MF; Laurent K; Langin D; Gauthier C
    Cardiovasc Res; 2003 Aug; 59(2):288-96. PubMed ID: 12909312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.
    Trochu JN; Leblais V; Rautureau Y; Bévérelli F; Le Marec H; Berdeaux A; Gauthier C
    Br J Pharmacol; 1999 Sep; 128(1):69-76. PubMed ID: 10498836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human atrial β(1L)-adrenoceptor but not β₃-adrenoceptor activation increases force and Ca(2+) current at physiological temperature.
    Christ T; Molenaar P; Klenowski PM; Ravens U; Kaumann AJ
    Br J Pharmacol; 2011 Feb; 162(4):823-39. PubMed ID: 20726983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenoceptor-mediated vascular relaxation in spontaneously hypertensive rats.
    Mallem Y; Holopherne D; Reculeau O; Le Coz O; Desfontis JC; Gogny M
    Auton Neurosci; 2005 Mar; 118(1-2):61-7. PubMed ID: 15795178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
    Imbrogno S; Angelone T; Adamo C; Pulerà E; Tota B; Cerra MC
    J Exp Biol; 2006 Dec; 209(Pt 24):4966-73. PubMed ID: 17142685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effect.
    Montastruc JL; Verwaerde P; Pelat M; Galitzky J; Langin D; Lafontan M; Berlan M
    Fundam Clin Pharmacol; 1999; 13(2):180-6. PubMed ID: 10226761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic beta-adrenoceptor blockade prevents the development of beta-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs.
    Liang CS; Frantz RP; Suematsu M; Sakamoto S; Sullebarger JT; Fan TM; Guthinger L
    Circulation; 1991 Jul; 84(1):254-66. PubMed ID: 1676348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tiapamil and nifedepine during critical coronary stenosis and in the presence of adrenergic beta-receptor blockade in anesthetized dogs.
    Saini RK; Fulmor IE; Antonaccio MJ
    J Cardiovasc Pharmacol; 1982; 4(5):770-6. PubMed ID: 6182408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
    Dessy C; Moniotte S; Ghisdal P; Havaux X; Noirhomme P; Balligand JL
    Circulation; 2004 Aug; 110(8):948-54. PubMed ID: 15302798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
    Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current.
    Skeberdis VA; Gendviliene V; Zablockaite D; Treinys R; Macianskiene R; Bogdelis A; Jurevicius J; Fischmeister R
    J Clin Invest; 2008 Sep; 118(9):3219-27. PubMed ID: 18704193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGP12177-induced haemodynamic and vascular effects in normotensive and hypertensive rats.
    Holopherne D; Mallem MY; Le Strat E; Belin de Chantemèle EJ; Gogny M; Henrion D; Noireaud J; Desfontis JC
    Eur J Pharmacol; 2008 Sep; 591(1-3):196-202. PubMed ID: 18601917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.
    Liang C; Doherty JU; Faillace R; Maekawa K; Arnold S; Gavras H; Hood WB
    J Clin Invest; 1982 Jun; 69(6):1321-36. PubMed ID: 6123523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat.
    Malinowska B; Schlicker E
    Br J Pharmacol; 1997 Dec; 122(7):1307-14. PubMed ID: 9421276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of two beta3-agonists, CGP 12177A and BRL 37344, on coronary flow and contractility in isolated guinea pig heart.
    Kozlovski VI; Chlopicki S; Gryglewski RJ
    J Cardiovasc Pharmacol; 2003 May; 41(5):706-13. PubMed ID: 12717100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
    Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc JL
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1444-51. PubMed ID: 7908057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β3-Adrenoceptor-mediated responses in diabetic rat heart.
    Kayki-Mutlu G; Arioglu-Inan E; Ozakca I; Ozcelikay AT; Altan VM
    Gen Physiol Biophys; 2014; 33(1):99-109. PubMed ID: 24334532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of the low-affinity state beta1-adrenoceptor-induced relaxation in spontaneously hypertensive rats.
    Mallem MY; Toumaniantz G; Serpillon S; Gautier F; Gogny M; Desfontis JC; Gauthier C
    Br J Pharmacol; 2004 Nov; 143(5):599-605. PubMed ID: 15466443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.